Following the vector

Zaytsev A.V.; Apolikhina I.A.; Bernikov A.N.; Kupriyanov Yu.A.; Khodyreva L.A.; Stroganov R.V.; Arefeva O.A.; Teterina T.A.

Зайцев А.В.

ФГБУ ВО «Российский университет медицины» Минздрава России

SPIN РИНЦ: 6223-5408
ORCID: 0000-0003-3044-1424

Аполихина И.А.

ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. В.И. Кулакова» Минздрава России

SPIN РИНЦ: 6282-7435
Scopus AuthorID: 8656342200
ORCID: 0000-0002-4581-6295

Берников А.Н.

ФГБУ ВО «Российский университет медицины» Минздрава России

SPIN РИНЦ: 9288-4518
ORCID: 0000-0001-8361-585X

Куприянов Ю.А.

ФГБУ ВО «Российский университет медицины» Минздрава России

SPIN РИНЦ: 5203-9824
Scopus AuthorID: 57205720468
ORCID: 0000-0002-5807-7591

Ходырева Л.А.

ГБУ «НИИОЗММ ДЗМ»

SPIN РИНЦ: 3565-5366
Scopus AuthorID: 6602548630
ORCID: 0000-0002-0751-4982

Строганов Р.В.

ФГБУ ВО «Российский университет медицины»;
ГБУ «НИИОЗММ ДЗМ»

SPIN РИНЦ: 2821-3446
Scopus AuthorID: 57196121153
ORCID: 0000-0002-5529-1787

Арефьева О.А.

ФГБУ ВО «Российский университет медицины»;
ГБУ «НИИОЗММ ДЗМ»

SPIN РИНЦ: 3287-8564
ORCID: 0000-0003-2309-2094

Тетерина Т.А.

SPIN РИНЦ: 6946-6759

Следуя вектору

Авторы:

Зайцев А.В., Аполихина И.А., Берников А.Н., Куприянов Ю.А., Ходырева Л.А., Строганов Р.В., Арефьева О.А., Тетерина Т.А.

Подробнее об авторах

Журнал: Non nocere. Новый терапевтический журнал. 2025;(7): 38‑44

Прочитано: 195 раз

Связаться с автором

Оглавление

Как цитировать:

Зайцев А.В., Аполихина И.А., Берников А.Н., и др. Следуя вектору. Non nocere. Новый терапевтический журнал. 2025;(7):38‑44.
Zaytsev AV, Apolikhina IA, Bernikov AN, et al. Following the vector. Non Nocere. New Therapeutic Journal. 2025;(7):38‑44. (In Russ.)

Использование инфографики авторами научных работ

Литература / References:

Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997 Sep;11(3):551-581. https://doi.org/10.1016/S0891-5520(05)70373-1
European Association of Urology. Guidelines. Urological Infections. https://uroweb.org/guidelines/urological-infections
Министерство здравоохранения Российской Федерации. Рубрикатор клинических рекомендаций. Клинические рекомендации. Цистит у женщин. ID: 14_3. Год утверждения: 2024. Дата обращения: 09.07.2025. https://cr.minzdrav.gov.ru/view-cr/14_3
Драпкина О.М., Сычев Д.А., Козлов Р.С., Пушкарь Д.Ю., Ливзан М.А., Цуканов А.Ю. Неосложненная инфекция нижних мочевыводящих путей (острый цистит) / Методические рекомендации. – М.: РОПНИЗ, ООО «Силицея-Полиграф», 2024. – 20 с.
Wagenlehner FME, Bjerklund Johansen TE, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020 Oct;17(10):586-600. https://doi.org/10.1038/s41585-020-0362-4
Gupta K, Trautner BW. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ. 2013 May 29;346: f3140. https://doi.org/10.1136/bmj.f3140
Rich SN, Klann EM, Almond CR, Larkin EM, Nicolette G, Ball JD. Associations between antibiotic prescriptions and recurrent urinary tract infections in female college students. Epidemiol Infect. 2019 Jan;147: e119. https://doi.org/10.1017/S0950268818003369
Hisano M, Bruschini H, Nicodemo AC, Srougi M. Uncomplicated Urinary Tract Infections in Women in a Sao Paulo Quaternary Care Hospital: Bacterial Spectrum and Susceptibility Patterns. Antibiotics (Basel). 2014 Mar 19;3(1):98-108. https://doi.org/10.3390/antibiotics3010098
Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J. 2015 Jun;26(6):795-804. https://doi.org/10.1007/s00192-014-2569-5
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014 Mar;28(1):1-13. https://doi.org/10.1016/j.idc.2013.09.003
Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt). 2012 Mar;21(3):347-354. https://doi.org/10.1089/jwh.2011.3056
Hooton TM, Stapleton AE, Roberts PL, et al. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis. 1999 Dec;29(6):1600-1601. https://doi.org/10.1086/313528
Гвоздев М.Ю., Лоран О.Б., Гумин Л.М., Дьяков В.В. Транспозиция дистального отдела уретры в оперативном лечении рецидивирующей инфекции нижних мочевыводящих путей у женщин. Урология. 2000;3:24-27.
Деревянко Т.И. Влагалищная эктопия наружного отверстия уретры как одна из причин хронического рецидивирующего цистита у женщин: диагностика и лечение. Урология. 2009;5:18-21.
Gyftopoulos K. The aberrant urethral meatus as a possible aetiological factor of recurrent post-coital urinary infections in young women. Med Hypotheses. 2018 Apr;113:6-8. https://doi.org/10.1016/j.mehy.2018.02.005
Vautrin N, Dahyot S, Leoz M, et al. Are Escherichia coli causing recurrent cystitis just ordinary uropathogenic E. coli (UPEC) strains? Virulence. 2024 Dec;16(1):2444689. https://doi.org/10.1080/21505594.2024.2444689
Козлов Р.С., Палагин И.С., Иванчик Н.В., и др. Национальный мониторинг антибиотико-резистентности возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового эпидемиологического исследования «ДАРМИС 2023». Клиническая микробиология и антимикробная химиотерапия. 2024;26(3):328-337. https://doi.org/10.36488/cmac.2024.3.328-337
Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011 Jun;108(24):415-423. https://doi.org/10.3238/arztebl.2011.0415
Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993 Oct 28;329(18):1328-1334. https://doi.org/10.1056/NEJM199310283291808
Foxman B, Somsel P, Tallman P, et al. Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol. 2001 Jul;54(7):710-718. https://doi.org/10.1016/s0895-4356(00)00352-8
van Buul LW, Vreeken HL, Bradley SF, et al. The Development of a Decision Tool for the Empiric Treatment of Suspected Urinary Tract Infection in Frail Older Adults: A Delphi Consensus Procedure. J Am Med Dir Assoc. 2018 Sep;19(9):757-764. https://doi.org/10.1016/j.jamda.2018.05.001
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002 May 22-29;287(20):2701-2710. https://doi.org/10.1001/jama.287.20.2701
Lifshitz E, Kramer L. Outpatient urine culture: does collection technique matter? Arch Intern Med. 2000 Sep 11;160(16):2537-2540. https://doi.org/10.1001/archinte.160.16.2537
Fihn SD. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med. 2003 Jul 17;349(3):259-266. https://doi.org/10.1056/NEJMcp030027
Flower A, Bishop FL, Lewith G. How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC Fam Pract. 2014 Sep 26;15:162. https://doi.org/10.1186/1471-2296-15-162
Leydon GM, Turner S, Smith H, Little P; UTIS team. Women’s views about management and cause of urinary tract infection: qualitative interview study. BMJ. 2010 Feb 5;340: c279. https://doi.org/10.1136/bmj.c279
Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):107-117. https://doi.org/10.1080/14737167.2017.1359543
Price JR, Guran LA, Gregory WT, McDonagh MS. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016 Nov;215(5):548-560. https://doi.org/10.1016/j.ajog.2016.07.040
Albert X, Huertas I, Pereiró II, Sanfélix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;2004(3):CD001209. https://doi.org/10.1002/14651858.CD001209.pub2
Bjerrum L, Lindbæk M. Which treatment strategy for women with symptoms of urinary tract infection? BMJ. 2015 Dec 29;351: h6888. https://doi.org/10.1136/bmj.h6888
Stapleton AE. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr. 2016 Dec;4(6):10.1128/microbiolspec.UTI-0025-2016. https://doi.org/10.1128/microbiolspec.uti-0025-2016
Pfau A, Sacks T. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. J Urol. 1981 Nov;126(5):630-634. https://doi.org/10.1016/s0022-5347(17)54661-3
Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017 Nov-Dec;168(9-10):782-792. https://doi.org/10.1016/j.resmic.2017.04.001
Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011 Mar 15;108 Suppl 1(Suppl 1):4680-4687. https://doi.org/10.1073/pnas.1002611107
Соловьева А.В., Гаче В. Нарушения биоценоза влагалища у женщин репродуктивного возраста. Акушерство и гинекология. 2017;4:126-131. https://doi.org/10.18565/aig.2017.4.126-31
van de Wijgert JHHM. The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention. PLoS Med. 2017 Dec 27;14(12): e1002478. https://doi.org/10.1371/journal.pmed.1002478
Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol. 2000 May;95(5):710-712. https://doi.org/10.1016/s0029-7844(99)00632-8
Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstet Gynecol. 2002 May;186(5):916-917. https://doi.org/10.1067/mob.2002.123987
Кульчавеня Е.В., Бреусов А.А. Рецидивирующий цистит и бактериальный вагиноз: как избежать полипрагмазии. Гинекология. 2020;22(4):17-21. https://doi.org/10.26442/20795696.2020.4.200275
Ильина И.Ю., Доброхотова Ю.Э. Бактериальный вагиноз. Возможные пути решения проблемы. РМЖ. 2020;11:75-78.
Аполихина И.А., Эфендиева З.Н. Современные направления в лечении бактериального вагиноза. Акушерство и гинекология. 2019;12:193-196. https://doi.org/10.18565/aig.2019.12.193-196
Jung H, Ehlers MM, Peters RPH, et al. Growth Forms of Gardnerella spp. and Lactobacillus spp. on Vaginal Cells. Front Cell Infect Microbiol. 2020 Feb 28;10:71. https://doi.org/10.3389/fcimb.2020.00071
Muzny CA, Taylor CM, Swords WE, et al. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. J Infect Dis. 2019 Sep 26;220(9):1399-1405. https://doi.org/10.1093/infdis/jiz342
Vaneechoutte M, Guschin A, Van Simaey L, Gansemans Y, Van Nieuwerburgh F, Cools P. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int J Syst Evol Microbiol. 2019 Mar;69(3):679-687. https://doi.org/10.1099/ijsem.0.003200
O’Brien VP, Hannan TJ, Nielsen HV, Hultgren SJ. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr. 2016 Feb;4(1):10.1128/microbiolspec.UTI-0013-2012. https://doi.org/10.1128/microbiolspec.uti-0013-2012
Lewis AL, Gilbert NM. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect Dis. 2020 Mar 26;8: Doc02. https://doi.org/10.3205/id000046
Ratten LK, Plummer EL, Murray GL, et al. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG. 2021 Mar;128(4):756-767. https://doi.org/10.1111/1471-0528.16430
Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med. 2025 Mar 6;392(10):947-957. https://doi.org/10.1056/NEJMoa2405404
Swidsinski A, Amann R, Guschin A, et al. Polymicrobial consortia in the pathogenesis of biofilm vaginosis visualized by FISH. Historic review outlining the basic principles of the polymicrobial infection theory. Microbes Infect. 2024 Nov–Dec;26(8):105403. https://doi.org/10.1016/j.micinf.2024.105403
Wagenlehner F, Nicolle L, Bartoletti R, et al. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance. J Glob Antimicrob Resist. 2022 Mar;28:18-29. https://doi.org/10.1016/j.jgar.2021.11.008
US Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Issued July 26, 2016. Accessed 18 June 2025. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain
European Medicines Agency (EMA). Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone fluoroquinolone antibiotics. EMA, Amsterdam, the Netherlands (2019). Accessed 18 June 2025. https://www.ema.europa.eu/en/documents/referral/quinolone-fluoroquinolone-article31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf.
Bratsman A, Mathias K, Laubscher R, Grigoryan L, Rose S. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning. Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):701-707. https://doi.org/10.1002/pds.5018
Cai T, Palagin I, Brunelli R, et al. Office-based approach to urinary tract infections in 50000 patients: results from the REWIND study. Int J Antimicrob Agents. 2020 Jul;56(1):105966. https://doi.org/10.1016/j.ijantimicag.2020.105966
Balaban NQ, Helaine S, Lewis K, et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019 Jul;17(7):441-448. https://doi.org/10.1038/s41579-019-0196-3
Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol. 2017 Aug;15(8):453-464. https://doi.org/10.1038/nrmicro.2017.42
Domenech M, Ramos-Sevillano E, García E, Moscoso M, Yuste J. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun. 2013 Jul;81(7):2606-2615. https://doi.org/10.1128/IAI.00491-13
Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 2003 Oct 15;171(8):4329-4339. https://doi.org/10.4049/jimmunol.171.8.4329
Jolivet-Gougeon A, Bonnaure-Mallet M. Biofilms as a mechanism of bacterial resistance. Drug Discov Today Technol. 2014 Mar;11:49-56. https://doi.org/10.1016/j.ddtec.2014.02.003
Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol. 2001 Dec;183(23):6746-6751. https://doi.org/10.1128/JB.183.23.6746-6751.2001
Liu SC, Han XM, Shi M, Pang ZL. Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies. J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):710-715. https://doi.org/10.1007/s11596-016-1649-9
Перепанова Т.С., Хазан П.Л. Растительный препарат Канефрон Н в лечении и профилактике инфекций мочевых путей. Врачебное сословие. 2005;4-5:1-4.
Dlin VV, Abramov-Sommariva D, Zakharova IN, et al. A non-interventional, prospective, multicenter study for evaluation of the use of the herbal medicinal product Canephron® N in the pediatric outpatient population in Russia. Clinical Phytoscience. 2018;4(1):31. https://doi.org/10.1186/s40816-018-0092-9
Höller M, Steindl H, Abramov-Sommariva D, Wagenlehner F, Naber KG, Kostev K. Treatment of Urinary Tract Infections with Canephron® in Germany: A Retrospective Database Analysis. Antibiotics (Basel). 2021 Jun 8;10(6):685. https://doi.org/10.3390/antibiotics10060685
Wagenlehner FM, Abramov-Sommariva D, Höller M, Steindl H, Naber KG. Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial. Urol Int. 2018;101(3):327-336. https://doi.org/10.1159/000493368a